General Catalyst led a $14m series A funding round in Welltheory.

General Catalyst, a venture capital firm investing in technology and healthcare innovation, led a $14m series A funding round in Welltheory, a company focused on delivering integrated autoimmune care through its digital health platform, with participation from 7wire Ventures, Ingeborg Investments, Accel, Box Group, Leaps by Bayer, and Up2 Opportunity Fund. “Employers and payers are urgently seeking solutions that improve outcomes while reducing costs. WellTheory’s AI-powered, whole-person model is proving it can do both. We are impressed by the company’s ability to deliver meaningful savings for its partners today while also setting a new standard for a personalized, consumer-first experience," Tiffany Yu, 7wire Ventures Principal.